PF-04360365 8.5 mg/kg

BIOLOGICAL2 trials

Sponsors

Pfizer

Conditions

Alzheimer's Disease

Phase 1

Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

CompletedNCT01125631

PfizerAlzheimer's Disease

Start: 2010-05-31End: 2011-08-31Updated: 2011-08-12

Phase 2

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

CompletedNCT00722046

PfizerAlzheimer's Disease

Start: 2008-12-05End: 2011-08-16Updated: 2022-11-07